The purpose of this bulletin is to highlight the inflated NHS price of haloperidol 500 microgram tablets and to demonstrate the potential savings of using alternative presentations to provide the same dose. It shows the current annual primary care spend on haloperidol 500 microgram tablets and potential annual opportunity within RDTC stakeholder ICBs.
The bulletin on the budget impact of prescribing haloperidol 500 microgram tablets can be accessed here